-
Rated 5.00 out of 5
Add to Cart
Retatrutide is an experimental triple-agonist (GLP-1, GIP, and glucagon) designed for obesity and type 2 diabetes, showing strong effects on weight loss and blood sugar control in early trials.
– 10mg vial
– ≥99% purity
– Lyophilized powder
– For research use only
Add to Cart
Retatrutide is an experimental triple-agonist (GLP-1, GIP, and glucagon) designed for obesity and type 2 diabetes, showing strong effects on weight loss and blood sugar control in early trials.
– 10mg vial
– ≥99% purity
– Lyophilized powder
– For research use only
-
Rated 5.00 out of 5
Add to Cart
Retatrutide is an experimental triple-agonist (GLP-1, GIP, and glucagon) designed for obesity and type 2 diabetes, showing strong effects on weight loss and blood sugar control in early trials
– 20mg vial
– ≥99% purity
– Lyophilized powder
– For research use only
Add to Cart
Retatrutide is an experimental triple-agonist (GLP-1, GIP, and glucagon) designed for obesity and type 2 diabetes, showing strong effects on weight loss and blood sugar control in early trials
– 20mg vial
– ≥99% purity
– Lyophilized powder
– For research use only
-
Add to Cart
Retatrutide is an experimental triple-agonist (GLP-1, GIP, and glucagon) designed for obesity and type 2 diabetes, showing strong effects on weight loss and blood sugar control in early trials
– 30mg vial
– ≥99% purity
– Lyophilized powder
– For research use only
Add to Cart
Retatrutide is an experimental triple-agonist (GLP-1, GIP, and glucagon) designed for obesity and type 2 diabetes, showing strong effects on weight loss and blood sugar control in early trials
– 30mg vial
– ≥99% purity
– Lyophilized powder
– For research use only
-
Add to Cart
Tirzepatide is a dual GIP and GLP-1 receptor agonist used to improve blood sugar control and support significant weight loss in type 2 diabetes and obesity.
– 20mg per vial
– ≥99% purity
– Lyophilized powder
– For research use only
Add to Cart
Tirzepatide is a dual GIP and GLP-1 receptor agonist used to improve blood sugar control and support significant weight loss in type 2 diabetes and obesity.
– 20mg per vial
– ≥99% purity
– Lyophilized powder
– For research use only
-
Add to Cart
Tirzepatide is a dual GIP and GLP-1 receptor agonist used to improve blood sugar control and support significant weight loss in type 2 diabetes and obesity.
– 30mg per vial
– ≥99% purity
– Lyophilized powder
– For research use only
Add to Cart
Tirzepatide is a dual GIP and GLP-1 receptor agonist used to improve blood sugar control and support significant weight loss in type 2 diabetes and obesity.
– 30mg per vial
– ≥99% purity
– Lyophilized powder
– For research use only
-
-
Rated 5.00 out of 5
Add to Cart
A 30mg Retatrutide research cartridge, reconstituted for consistent precision.
– Twelve 2.5mg doses or thirty 1mg doses
- Purity Pen compatible
- Shipped with cold pack
– For research use only
Add to Cart
A 30mg Retatrutide research cartridge, reconstituted for consistent precision.
– Twelve 2.5mg doses or thirty 1mg doses
– Purity Pen compatible
– Shipped with cold pack
– For research use only
-
Add to Cart
Tirzepatide is a dual GIP and GLP-1 receptor agonist used to improve blood sugar control and support significant weight loss in type 2 diabetes and obesity.
A 30mg Tirzepatide research cartridge, reconstituted for consistent precision.
– Twelve 2.5mg doses or thirty 1mg doses
– Purity Pen compatible
– Shipped with cold pack
– For research use only
Add to Cart
Tirzepatide is a dual GIP and GLP-1 receptor agonist used to improve blood sugar control and support significant weight loss in type 2 diabetes and obesity.
A 30mg Tirzepatide research cartridge, reconstituted for consistent precision.
– Twelve 2.5mg doses or thirty 1mg doses
– Purity Pen compatible
– Shipped with cold pack
– For research use only
